| 101619-5 | CMS - Referral during assessment period | PANEL.SURVEY.CMS |
| 10162-6 | History of pregnancies Narrative | H&P.HX |
| 101620-3 | CMS - Referral has been made to the local contact agency during assessment period Patient education material (qualitative) | SURVEY.CMS |
| 101621-1 | CMS - Reason referral to local contact agency not made during assessment period | SURVEY.CMS |
| 101622-9 | CMS - Correction Request during assessment period | PANEL.SURVEY.CMS |
| 101623-7 | Semen --post ejaculation (Urine) | FERT |
| 101624-5 | Spermatozoa Agglutinated Qualitative (Urine, qualitative, light microscopy --post ejaculation) | FERT |
| 101625-2 | Spermatozoa.motility Qualitative (Semen, qualitative, light microscopy) | FERT |
| 101626-0 | Thyroglobulin heterophile Ab interference panel - Serum | PANEL.CHEM |
| 101627-8 | Thyroglobulin heterophile Ab interference (qualitative) | CHEM |
| 101628-6 | Thyroglobulin heterophile Ab interference Narrative | CHEM |
| 101629-4 | Hypoglycemia evaluation panel - Serum or Plasma | PANEL.CHEM |
| 10163-4 | History of pregnancies | H&P.HX |
| 101630-2 | JAK2 gene rearrangements or Marrow (Blood, fish) | MOLPATH.REARRANGE |
| 101631-0 | JAK2 gene rearrangements or Tissue (Blood, fish) | MOLPATH.REARRANGE |
| 101632-8 | CMS - Nutritional approaches - on admission during assessment period | SURVEY.CMS |
| 101633-6 | MT-RNR1 gene targeted mutation analysis or Tissue (Blood, molecular genetics method) | MOLPATH.MUT |
| 101634-4 | HBB gene deletion and duplication mutation analysis or Tissue (Blood, mlpa) | MOLPATH.DELDUP |
| 101635-1 | USP6 gene rearrangements or Tissue (Blood, fish) | MOLPATH.REARRANGE |
| 101636-9 | TCRB gene and TCRG gene rearrangements (Bone Marrow, molecular genetics method) | MOLPATH.REARRANGE |
| 101637-7 | TCRB gene and TCRG gene rearrangements or Tissue (Blood, molecular genetics method) | MOLPATH.REARRANGE |
| 101638-5 | TCRB gene and TCRG gene rearrangements in Specimen (molecular genetics method) | MOLPATH.REARRANGE |
| 101639-3 | PDGFB gene rearrangements or Tissue (Blood, fish) | MOLPATH.REARRANGE |
| 10164-2 | History of Present illness Narrative | H&P.HX |
| 101640-1 | NUTM1 gene rearrangements or Tissue (Blood, fish) | MOLPATH.REARRANGE |
| 101641-9 | Myeloid sarcoma analysis or Tissue (Blood, fish) | MOLPATH |
| 101642-7 | Cardiovascular risk panel - Serum or Plasma | PANEL.MOLPATH |
| 101643-5 | CD3 cells --after stimulation with SARS-CoV-2 Nucleocapsid peptide (Blood) | MICRO |
| 101644-3 | CD3+CD4+ (T4 helper) cells --after stimulation with SARS-CoV-2 Nucleocapsid peptide (Blood) | MICRO |
| 101645-0 | CD3+CD8+ (T8 suppressor) cells --after stimulation with SARS-CoV-2 Nucleocapsid peptide (Blood) | MICRO |
| 101646-8 | Candida albicans, C. dubliniensis, C. parapsilosis, and C. tropicalis DNA in Vaginal fluid (qualitative, naa with probe detection) | MICRO |
| 101647-6 | Ehrlichiosis and Anaplasmosis and Babesiosis and Borrelia miyamotoi DNA panel - Serum, Plasma or Blood (naa with probe detection) | PANEL.MICRO |
| 101648-4 | 14-3-3 Ag (CSF, immunoassay) | CHEM |
| 101649-2 | Tau protein (CSF, immunoassay) | CHEM |
| 10165-9 | History of psychiatric symptoms and diseases Narrative | H&P.HX |
| 101650-0 | Prion disease risk (CSF, immunoassay narrative) | CHEM |
| 101651-8 | MYC and BCL2 rearrangements (Tissue, fish) | MOLPATH |
| 101652-6 | Somatotropin and glucose post glucose stimulation panel - Serum or Plasma | PANEL.CHAL |
| 101653-4 | Prenatal hepatitis B and C panel - Serum or Plasma | PANEL.MICRO |
| 101654-2 | Neonatal ABO, Rh and DAT panel - Blood from Newborn | PANEL.BLDBK |
| 101655-9 | Basic metabolic and hematocrit panel - Blood | PANEL.CHEM |
| 101656-7 | Lactate and pyruvate panel - Serum, Plasma or Blood | PANEL.CHEM |
| 101657-5 | Special investigation unit (SIU) medical record request Document | DOC.MISC |
| 101658-3 | Cancer staging after multimodality therapy | ONCOLOGY |
| 101659-1 | Cancer staging after tumor recurrence | ONCOLOGY |
| 10166-7 | History of Social function Narrative | H&P.HX |
| 101660-9 | Cancer staging during autopsy | ONCOLOGY |
| 101661-7 | Tumor marker level Serum | ONCOLOGY |
| 101662-5 | Abnormal Prion Protein (CSF, qualitative, rt-quic) | CHEM |
| 101663-3 | T-Cell acute lymphoblastic leukemia or Tissue (Blood, fish) | MOLPATH |